Literature DB >> 18586631

Lymphatic spread of pagetic osteogenic sarcoma detected by bone scan.

Alexandre Arkader1, Carol D Morris.   

Abstract

Bone scans are widely utilized for detection of metastases from bone sarcomas. Technetium methylene diphosphonate scan ([(99m)Tc]MDP) is one of the most popular radiotracers used for that purpose. Lymphatic spread of bone sarcomas is unusual and often difficult to diagnose. Unfortunately, bone scans are not as sensitive in demonstrating lymphatic spread of sarcomas as they are at demonstrating hematogenous spread. A bone scan will often fail to demonstrate lymph nodes metastases until there is mineralization at the affected node. In this report, we highlight an interesting case of a patient with secondary osteogenic sarcoma (OS) from Paget's disease in the distal femur with non-ossified inguinal nodal metastasis diagnosed with [(99m)Tc]MDP. Lymph node involvement was not appreciated on plain radiographs or computed tomography (CT).

Entities:  

Mesh:

Year:  2008        PMID: 18586631      PMCID: PMC2442384          DOI: 10.1102/1470-7330.2008.0021

Source DB:  PubMed          Journal:  Cancer Imaging        ISSN: 1470-7330            Impact factor:   3.909


Case report

A 72-year-old male presented to our clinic with a 3-month history of progressive right knee pain associated with swelling and stiffness; this pain was exacerbated by activity and alleviated with narcotics. The past medical history was significant for Paget's disease of several years duration. Physical examination showed a decreased range of motion of the knee (5–120 degrees), mild swelling and elevated temperature, tenderness on palpation of the distal femur, no signs of ligamentous or meniscal injuries. No lymph nodes were palpated throughout the lower extremities and were not enlarged. The plain radiographs (Fig. 1) demonstrated an aggressive bone-forming lesion of the right distal femur. Magnetic resonance imaging and computerized scan confirmed the extent of the soft tissue mass. [99mTc]MDP scintigraphy showed increased activity at the lesion site (Fig. 2) and identified an increased uptake of radiotracer localized in the lymph nodes of the right inguinal region. The plain film of the pelvis (Fig. 3), along with other imaging exams, did not show any abnormalities in the inguinal region.

Anterior–posterior (A) and lateral (B) plain radiographs of the right knee demonstrate an ill-defined, bone-forming, aggressive looking lesion of the distal femur (arrows).

Three-phase [

Anterior–posterior (A) radiograph of the pelvis does not demonstrate the inguinal lymph node that was identified on the bone scan.

Anterior–posterior (A) and lateral (B) plain radiographs of the right knee demonstrate an ill-defined, bone-forming, aggressive looking lesion of the distal femur (arrows). Three-phase [ Anterior–posterior (A) radiograph of the pelvis does not demonstrate the inguinal lymph node that was identified on the bone scan. An incisional biopsy of the bony lesion and excisional biopsy of the lymph nodes confirmed the diagnosis of metastatic osteogenic sarcoma (OS). Following a wide resection of the right femoral mass and endoprosthetic reconstruction, chemotherapy was administered. Despite all efforts the patient developed widespread metastatic disease and died 6 months post-operatively, due to pulmonary complications.

Discussion

Approximately 15–20% of patients with OS will present with metastases at time of diagnosis[. OS generally spreads through the blood stream and as a result, the most common site for metastases is the lung, followed by bones and soft tissues[. Lymphatic spread of sarcomas, particularly OS is rare and likely represents less than 3% of all cases[. Weingrad reported a 2.6% incidence (3/374 patients) of lymphatic spread with OS5. Ceceres et al. reported an incidence of regional lymph nodes metastases in OS of 10.4%. This series included 182 consecutive patients with operable OS that underwent radical surgery and lymph node dissection6. The estimated incidence of sarcomas in patients with Paget's disease is less than 1%7 however some have reported rates as high as 10%[. In a review of 1649 OS, only 54 (3.3%) arose in pagetic bone10. Radiographic features of OS vary depending on the level of osteoblastic activity. This is especially true for bone scans. Non-osseous lesions are better identified when osteoblastic activity produces ossification. Although rare, mineralized lymph nodes are more readily detected on bone scan than non-mineralized nodes2. Bone scans are a cost-effective and sensitive method for detection of lung, osseous and soft-tissue metastases associated with OS11. Bone scans also usually reveal areas of intense tracer activity with or without extension into the soft tissue adjacent to the bone[. One drawback to bone scans is that other bones in the extremity bearing the tumor may show mild to moderate diffusely increased uptake. This uptake may be more intense around the joints, a finding known as ‘extended pattern’14. Bone scans are also useful in the detection of multicentric OS13. Bone scans with [99mTc]MDP have been widely used for detection of lung and skeletal metastases from OS, often detecting disease before other imaging modalities15. Paget's disease usually presents with increased activity of radiotracer uptake16; however OS secondary to Paget's disease often has a photon-deficient pattern17. In one previous study, conducted at our institution, 85 patients with bone sarcoma associated with Paget's disease were reviewed, [99mTc]MDP was cold (negative), while gallium uptake was often observed17. Gallium scans were also shown to be more useful in defining the likelihood of malignant degeneration, and the disease extent7. Heyman, the first to report the detection of lymphatic spread of OS by [99mTc]MDP18, concluded that bone scans are a valuable tool for following the progression of the disease. Caner et al.19 reported a case of metastatic lymph node from an OS of the tibia using hexakis technetium (Tc-MIBI) following a negative three-phase [99mTc]MDP. Positive bone scans have been described in patients with calcified lymph nodes associated with primary OS, however in these cases it is usually possible to make the diagnosis concomitantly with plain films, computed tomography (CT) or magnetic resonance imaging (MRI)[. Tobias reported lymphatic metastases of OS in 4 of 176 patients, however one other patient presented with calcified lymph nodes in the absence of metastatic disease. It did not seem that patients with lymphatic spread had a different prognosis than those with hematogenous spread4. Bone scans are not routinely used for the detection of lymph node metastases, however, in the present case, it was useful in identifying an uncommon site of metastasis. For staging purposes gallium scans seem to be more reliable when the diagnosis of lymphatic spread is suspected.
  19 in total

Review 1.  Bone scintigraphy in benign and malignant tumors.

Authors:  M L Brown
Journal:  Radiol Clin North Am       Date:  1993-07       Impact factor: 2.303

Review 2.  Incidence of regional lymph node metastasis in operable osteogenic sarcoma.

Authors:  E Caceres; M Zaharia; R Calderon
Journal:  Semin Surg Oncol       Date:  1990

3.  Significance of the solitary lesion in pediatric bone scanning: concise communication.

Authors:  M L Brown
Journal:  J Nucl Med       Date:  1983-02       Impact factor: 10.057

4.  Bone sarcomas in Paget disease: a study of 85 patients.

Authors:  J Smith; J F Botet; S D Yeh
Journal:  Radiology       Date:  1984-09       Impact factor: 11.105

Review 5.  Radiation and pagetic osteogenic sarcomas.

Authors:  J H Healey; D Buss
Journal:  Clin Orthop Relat Res       Date:  1991-09       Impact factor: 4.176

6.  Osteosarcoma with calcified regional lymph nodes.

Authors:  P Nouyrigat; J F Berdah; B Roullet; J P Olivier
Journal:  Pediatr Radiol       Date:  1993

7.  Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns.

Authors:  F S Chew; T M Hudson
Journal:  AJR Am J Roentgenol       Date:  1982-07       Impact factor: 3.959

8.  Increased accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in osteosarcoma and its metastatic lymph nodes.

Authors:  B Caner; M Kitapçi; T Aras; G Erbengi; O Uğur; C Bekdik
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

9.  Osteogenic sarcoma with clinically detectable metastasis at initial presentation.

Authors:  P A Meyers; G Heller; J H Healey; A Huvos; A Applewhite; M Sun; M LaQuaglia
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

10.  The significance of calcified regional lymph nodes at the time of diagnosis of osteosarcoma.

Authors:  J D Tobias; C B Pratt; D M Parham; A A Green; B Rao
Journal:  Orthopedics       Date:  1985-01       Impact factor: 1.390

View more
  3 in total

Review 1.  Targeting polymer therapeutics to bone.

Authors:  Stewart A Low; Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-01-28       Impact factor: 15.470

2.  Popliteal lymph node metastasis of tibial osteoblastic osteosarcoma.

Authors:  Yalın Dirik; Arda Çınar; Feridun Yumrukçal; Levent Eralp
Journal:  Int J Surg Case Rep       Date:  2014-10-13

3.  Regional lymph node involvement is associated with poorer survivorship in patients with upper extremity osteosarcoma than with lower extremity osteosarcoma: a SEER analysis.

Authors:  Xianbiao Xie; Ziliang Zeng; Jian Tu; Hao Yao; Yiying Bian; Qinglin Jin; Dongming Lv; Bo Wang; Jingnan Shen
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.